295 related articles for article (PubMed ID: 26669672)
21. Eptinezumab: First Approval.
Dhillon S
Drugs; 2020 May; 80(7):733-739. PubMed ID: 32266704
[TBL] [Abstract][Full Text] [Related]
22. The CGRP Pathway in Migraine as a Viable Target for Therapies.
Edvinsson L
Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
Goadsby PJ
Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
[TBL] [Abstract][Full Text] [Related]
24. A novel formulation of veggies with potent anti-migraine activity.
Jain MM; Kumari N; Rai G
Int J Comput Biol Drug Des; 2015; 8(1):54-61. PubMed ID: 25869319
[TBL] [Abstract][Full Text] [Related]
25. Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
Levin M; Silberstein SD; Gilbert R; Lucas S; Munsie L; Garrelts A; Kennedy K; Everman N; Pearlman E
Headache; 2018 Nov; 58(10):1689-1696. PubMed ID: 30426478
[TBL] [Abstract][Full Text] [Related]
26. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
Benemei S; Nicoletti P; Capone JA; Geppetti P
Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
[TBL] [Abstract][Full Text] [Related]
27. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
Tringali G; Navarra P
Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
[TBL] [Abstract][Full Text] [Related]
28. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
Edvinsson L
Br J Clin Pharmacol; 2015 Aug; 80(2):193-9. PubMed ID: 25731075
[TBL] [Abstract][Full Text] [Related]
29. Switching CGRP(r) MoAbs in migraine: what evidence?
Wells-Gatnik WD; Martelletti P
Expert Opin Biol Ther; 2024 May; 24(5):327-333. PubMed ID: 38726800
[TBL] [Abstract][Full Text] [Related]
30. Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.
Szperka CL; VanderPluym J; Orr SL; Oakley CB; Qubty W; Patniyot I; Lagman-Bartolome AM; Morris C; Gautreaux J; Victorio MC; Hagler S; Narula S; Candee MS; Cleves-Bayon C; Rao R; Fryer RH; Bicknese AR; Yonker M; Hershey AD; Powers SW; Goadsby PJ; Gelfand AA
Headache; 2018 Nov; 58(10):1658-1669. PubMed ID: 30324723
[No Abstract] [Full Text] [Related]
31. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
Dodick DW
Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
[TBL] [Abstract][Full Text] [Related]
32. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
33. CGRP - a target for acute therapy in migraine: Clinical data.
Messina R; Goadsby PJ
Cephalalgia; 2019 Mar; 39(3):420-427. PubMed ID: 29616830
[TBL] [Abstract][Full Text] [Related]
34. A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
Reuter U
Headache; 2018 May; 58 Suppl 1():48-59. PubMed ID: 29697156
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
Schuster NM; Rapoport AM
Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
37. Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
Holland PR
Headache; 2018 May; 58 Suppl 1():1-3. PubMed ID: 29697155
[No Abstract] [Full Text] [Related]
38. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
[TBL] [Abstract][Full Text] [Related]
39. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
Tepper DE
Headache; 2019 Mar; 59(3):477-480. PubMed ID: 30825209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]